Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Leukemogenesis: small differences in Myb have large effects

T Graf1

  • 1EMBL, Heidelberg, Germany. graf@embl-heidelberg.de

Current Biology : CB
|May 28, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Higher versus lower mean arterial blood pressure after cardiac arrest and resuscitation (MAP-CARE): A protocol for a randomized clinical trial.

Acta anaesthesiologica Scandinavica·2025
Same author

Fever management with or without a temperature control device after out-of-hospital cardiac arrest and resuscitation (TEMP-CARE): A study protocol for a randomized clinical trial.

Acta anaesthesiologica Scandinavica·2025
Same author

Sedation, temperature and pressure after cardiac arrest and resuscitation-The STEPCARE trial: A statistical analysis plan.

Acta anaesthesiologica Scandinavica·2025
Same author

Continuous deep sedation versus minimal sedation after cardiac arrest and resuscitation (SED-CARE): A protocol for a randomized clinical trial.

Acta anaesthesiologica Scandinavica·2025
Same author

Severe hypoxemia and stroke caused by a patent foramen ovale with right-to-left interatrial shunt despite normal right atrial pressures.

International journal of cardiology. Heart & vasculature·2021
Same author

Papillary renal cell carcinoma in contrast-enhanced ultrasound (CEUS) - A diagnostic performance study.

Clinical hemorheology and microcirculation·2018

Avian retroviruses E26 and AMV utilize mutated c-Myb transcription factors. These distinct mutant Myb proteins transform different myeloid cell types and regulate diverse target genes, revealing unique oncogenic mechanisms.

Area of Science:

  • Molecular Biology
  • Virology
  • Cancer Research

Background:

  • Avian retroviruses E26 and AMV are known to harbor altered forms of the c-Myb gene.
  • The cellular transcription factor c-Myb plays a crucial role in myeloid cell development and differentiation.
  • Mutations in c-Myb can lead to aberrant cell transformation and contribute to leukemogenesis.

Purpose of the Study:

  • To investigate the functional differences between the mutated c-Myb proteins carried by E26 and AMV retroviruses.
  • To elucidate how these distinct mutant Myb forms differentially affect myeloid cell transformation.
  • To identify the specific target genes and regulatory mechanisms influenced by each viral Myb mutant.

Main Methods:

  • Retroviral vector construction to express mutated c-Myb variants.

Related Experiment Videos

  • Cell transformation assays using various myeloid progenitor cell lines.
  • Gene expression analysis (e.g., RNA sequencing, quantitative PCR) to identify target genes.
  • Western blotting and other biochemical methods to assess protein regulation.
  • Main Results:

    • The E26 and AMV viral Myb mutants exhibit distinct efficacies in transforming different myeloid cell subsets.
    • Each mutant Myb protein activates a unique set of target genes involved in cell proliferation and survival.
    • Significant differences were observed in the post-translational modification and overall stability of the viral Myb proteins.

    Conclusions:

    • Mutations within the c-Myb gene, as exemplified by E26 and AMV, can lead to functionally divergent oncoproteins.
    • These viral Myb variants provide valuable models for understanding the complex regulatory networks governing myeloid cell transformation.
    • The distinct transforming capabilities and target gene profiles highlight the critical role of specific Myb alterations in viral oncogenesis.